{"dmca":{"id":25444,"type":"Dmca","title":"[ThePlanetAbuse-C3813066E] DMCA Notification ISP Follow-up - www.taldalafil.com - Eli","body":"-----Original Message-----\r\nFrom: abuse@theplanet.com [mailto:abuse@theplanet.com] \r\nSent: Tuesday, April 10, 2007 10:48 AM\r\nTo: Copyright\r\nSubject: [ThePlanetAbuse-C3813066E] DMCA Notification ISP Follow-up -\r\nwww.taldalafil.com - Eli Lilly ICOS (Cialis)\r\n\r\n==== Forwarded Ticket ====\r\n1. DMCA Notification ISP Follow-up -  www.taldalafil.com - Eli Lilly ICOS (Cialis)\r\nAdded by system at Tuesday, Apr 10 2007 03:47 pm \r\nX-MailFrom: cmcintosh@netenforcers.com \r\nX-RcptTo: abacus@abacus.ev1servers.net \r\nReceived: from [216.12.192.67] by [216.12.192.78] (abacus) for\r\n<abacus@abacus.ev1servers.net>; Tue Apr 10 15:47:27 2007 \r\nReceived: (qmail 30217 invoked by alias); 10 Apr 2007 20:47:26 -0000 \r\nDelivered-To: abuse@inbound.abacus.ev1servers.net \r\nReceived: (qmail 30214 invoked from network); 10 Apr 2007 20:47:26 -0000 \r\nReceived: from unknown (HELO DALD2EXCH01.PLANET.LOCAL) (172.16.220.10) \r\n  by inbound.abacus.ev1servers.net with SMTP; 10 Apr 2007 20:47:26 -0000 \r\nReceived: from Exchanger.ev1servers.net ([207.218.222.101]) by\r\nDALD2EXCH01.PLANET.LOCAL with Microsoft SMTPSVC(6.0.3790.1830); \r\n  Tue, 10 Apr 2007 15:47:26 -0500 \r\nReceived: from mailin.ev1servers.net ([207.218.222.124]) by Exchanger.ev1servers.net\r\nwith Microsoft SMTPSVC(6.0.3790.1830); \r\n  Tue, 10 Apr 2007 15:47:26 -0500 \r\nX-ASG-Debug-ID: 1176238040-25633-847-0 \r\nX-Barracuda-URL: http://207.218.222.124:8000/cgi-bin/mark.cgi \r\nX-ASG-Recipient-Whitelist:  abuse@ev1servers.net \r\nReceived: from outbound.mse9.exchange.ms (outbound.mse9.exchange.ms [69.25.50.217]) \r\n        by mailin.ev1servers.net (Spam Firewall) with ESMTP id BBA4E70204 \r\n        for <abuse@ev1servers.net>; Tue, 10 Apr 2007 15:47:25 -0500 (CDT) \r\nX-MimeOLE: Produced By Microsoft Exchange V6.5 \r\nContent-class: urn:content-classes:message \r\nMIME-Version: 1.0 \r\nContent-Type: multipart/related; \r\n        type=\"multipart/alternative\"; \r\n        boundary=\"----_=_NextPart_001_01C77BB1.68DF18AC\" \r\nX-ASG-Orig-Subj: DMCA Notification ISP Follow-up -  www.taldalafil.com - Eli Lilly\r\nICOS (Cialis)  \r\nSubject: DMCA Notification ISP Follow-up -  www.taldalafil.com - Eli Lilly ICOS\r\n(Cialis)  \r\nDate: Tue, 10 Apr 2007 16:47:10 -0400 \r\nMessage-ID: <D86F07BB66395C43A311B078855B2B5A0216AA46@ms17.mse9.exchange.ms> \r\nX-MS-Has-Attach: yes \r\nX-MS-TNEF-Correlator:  \r\nThread-Topic: DMCA Notification ISP Follow-up -  www.taldalafil.com - Eli Lilly ICOS\r\n(Cialis)  \r\nThread-Index: Acd7sRr70mPMHVG4R0GrNuID/SXKVw== \r\nFrom: \"Casey McIntosh\" <cmcintosh@netenforcers.com> \r\nTo: <abuse@ev1servers.net> \r\nX-Virus-Scanned: by Barracuda Spam Firewall at ev1servers.net \r\nX-Barracuda-Spam-Score: 0.00 \r\nX-Barracuda-Spam-Status: No, SCORE=0.00 using global scores of TAG_LEVEL=4.0\r\nQUARANTINE_LEVEL=1000.0 KILL_LEVEL=8.0 WHITELISTED  \r\nReturn-Path: cmcintosh@netenforcers.com \r\nX-OriginalArrivalTime: 10 Apr 2007 20:47:26.0463 (UTC) FILETIME=[728D28F0:01C77BB1] \r\n\r\n (multipart/related) \r\nMultipart prefix (text/plain) \r\nThis is a multi-part message in MIME format. \r\n \r\n (multipart/alternative) \r\nMIME element (text/plain) \r\nTo whom it may concern, \r\n \r\n  \r\n \r\nThis is in regards to a Cease and Desist letter which was sent to you regarding your\r\nclient www.Taldalafil.com <http://www.taldalafil.com/>  and our client Eli Lilly\r\nICOS (Cialis). Your client received a DMCA Notification informing them of the\r\nunauthorized use of copyrighted images and trademarked logos. They received this\r\nletter on 3/27/2007 and was given eight (8) days to comply. The website has been\r\nrechecked and I am showing your client has yet to comply. In regards to this issue,\r\nit should be known that the advertisement or sale of \"Generic Cialis\" is forbidden\r\ninside the US. Simply hosting a website that offers \"Generic Cialis\" is illegal.\r\nAlso, the removal of all infringing Intellectual Property  owned by Eli Lilly ICOS\r\n(Cialis) must be done to meet compliance. Please provide me with a follow-up on this\r\nby 4/13/2007. If you have any questions please do not hesitate to contact me via\r\nemail at CMcIntosh@Netenforcers.com. \r\n \r\n  \r\n \r\nSincerely, \r\n \r\n  \r\n \r\n  \r\n \r\nCasey McIntosh \r\n \r\nLMS Representative \r\n \r\nNet Enforcers Inc. \r\n \r\nCMcIntosh@netenforcers.com \r\n \r\ncompliance.management@netenforcers.com \r\n \r\n  \r\n \r\nThe Online Enforcement Specialists...... \r\n \r\nStatement of Confidentiality \r\n \r\nThe contents of this e-mail message and any attachments are confidential and are\r\nintended solely for the addressee. The information may also be legally privileged.\r\nThis transmission is sent in trust, for the sole purpose of delivery to the intended\r\nrecipient. If you have received this transmission in error, any use, reproduction or\r\ndissemination of this transmission is strictly prohibited. If you are not the\r\nintended recipient, please immediately notify the sender by reply e-mail and delete\r\nthis message and it's attachments, if any. Thank you. \r\n \r\n  \r\n \r\nOriginal ISP Letter: \r\n \r\n  \r\n \r\n3/27/2007  \r\n \r\n7155 5474 4100 4343 8465 \r\n \r\n  \r\n \r\n  \r\n \r\nVIA CERTIFIED US MAIL \r\n \r\nRETURN RECEIPT REQUESTED \r\n \r\n  \r\n \r\n  \r\n \r\nEveryones Internet \r\n \r\nEveryones Internet \r\n \r\n390 Benmar Suite 200 \r\n \r\nHouston TX 77060 \r\n \r\n  \r\n \r\n  \r\n \r\n  \r\n \r\nRe:      Notification of Copyright & Trademark Infringement   \r\n \r\n            Violation of Terms of Service \r\n \r\n            www.Taldalafil.com \r\n \r\n  \r\n \r\nDear Sir or Madam:  \r\n \r\n  \r\n \r\nOur law firm represents Lilly ICOS LLC (\"Lilly ICOS\"), owner of the CIALIS\u00ae\r\n(tadalafil) prescription pharmaceutical product for the treatment of erectile\r\ndysfunction.  This letter constitutes notification of claims of copyright\r\ninfringement and/or trademark infringement, dilution, and unfair competition and\r\nviolation of your Terms of Service. \r\n \r\n  \r\n \r\nLilly ICOS is the owner of the intellectual property rights in the CIALIS product. \r\nThe CIALIS (tadalafil) compound and method of use are covered under U.S. Patent Nos.\r\n5,859,006 and 6,140,329.  The CIALIS trademark, the \"swirl\" logo, and the appearance\r\nof the CIALIS tablet are protected under U.S. Trademark Reg. Nos. 2,724,589,\r\n2,833,221, and 2,833,222.  The unique packaging for the CIALIS product, including\r\nthe swirl logo, is protected by copyright, and has been registered with the U.S.\r\nCopyright Office under Reg. No. TX-5-713-466.  The phrase or words \"Generic CIALIS\"\r\nis also copyrighted by Lilly ICOS, and its use is prohibited in the sale or\r\nadvertised sale of Tadalafil (Generic CIALIS). These copyrighted works are entitled\r\nto protection against unauthorized reproduction, distribution, and display pursuant\r\nto U.S. and international copyright laws.  Any person who uses the Lilly ICOS\r\ntrademark-protected intellectual property in a manner which is likely to cause\r\nconfusion,!\r\n  cause mistake, or deceive consumers into believing that their product or website\r\nis sponsored by or affiliated with Lilly ICOS is in violation of Lilly ICOS'\r\nrights under U.S. law. It is illegal to sell \"Generic CIALIS\" or any other product\r\ncontaining tadalafil (other than authentic CIALIS) in the US or host a website\r\nselling Generic CIALIS into the US. It is also a violation of intellectual\r\nproperty to use the term Generic CIALIS. Copies of the copyright and trademark\r\ncertificates of registration will be provided upon request. \r\n \r\n  \r\n \r\nIt is our understanding that you host the website located at www.Taldalafil.com\r\n(Taldalafil.com).  Below are examples of infringing URLs hosted by the Website which\r\nillustrate the unauthorized use of the trademark-protected CIALIS brand name.  This\r\nWebsite uses the trademark-protected CIALIS brand name to market such products as\r\n\"Cialis (Apcalis)\" tablets. The CIALIS trademark is also used in the source code and\r\nmetatags for the site.  Additionally, the Website displays a tablet which is\r\nidentical or confusingly similar to the trademark-protected tablet design.   \r\n \r\n  \r\n \r\nhttp://taldalafil.com/ \r\n \r\n  \r\n \r\nThe www.Taldalafil.com site uses the trademark-protected CIALIS brand name on the\r\nsite and in the source code and metatags for the site. \r\n \r\n  \r\n \r\nThe use of the CIALIS brand copyright-protected and/or trademark-protected materials\r\non these sites is without any permission whatsoever from Lilly ICOS or its\r\nauthorized agents.  Such actions are in violation of Lilly ICOS' rights in its\r\nintellectual property under federal law and the materials on these sites constitute\r\nan ongoing infringement of Lilly ICOS' trademarks.   \r\n \r\n  \r\n \r\nThese sites' purpose is to import and sell \"Cialis (Apcalis)\" tablets, which is\r\nparticularly alarming because the United States Food and Drug Administration has not\r\napproved these medications for sale in the U.S.  The sale and/or import of the\r\npurported \"Cialis (Apcalis)\" tablets into the U.S. is in violation of U.S. law\r\nincluding, but not limited to, the Federal Food, Drug and Cosmetic Act, 21 U.S.C. \u00a7\r\n301 et. seq., 21 U.S.C. \u00a7 355 (unapproved drug) and/or 21 U.S.C. \u00a7 352 (improper\r\nor unapproved labeling).  Additionally, on June 13, 2006, the U.S. International\r\nTrade Commission issued a General Exclusion Order under 19 U.S.C. \u00a7 1337(G)(2)\r\nprohibiting the unlicensed importation into the U.S. of tadalafil or any salt or\r\nsolvate thereof, and products containing same, covered by one or more claims 1-4,\r\n6-8, 12 and 13 of '006 patent.   \r\n \r\n  \r\n \r\nWe also believe that this website, www.Taldalafil.com, is in violation of your\r\nterms/rules prohibiting use of Everyones Internet's services for unlawful purposes.\r\nWe ask you to investigate such a breach and enforce your terms/rules. \r\n \r\nBy marketing unapproved and illegal counterfeit drugs, your customer also may be\r\nadversely affecting your public image, reputation and goodwill.  \r\n \r\n  \r\n \r\nLilly ICOS also owns patent rights in the U.S. and throughout the world for its\r\nCIALIS product.  This letter is written without prejudice to any other rights of\r\nLilly ICOS LLC, including but not limited to claims for patent infringement. \r\n \r\n  \r\n \r\nIf you have questions, please contact Net Enforcers' Compliance Management\r\nDepartment via facsimile to 352-505-0040, or via email to\r\nCompliance.Management@NetEnforcers.com.  All communication must be in writing. Net\r\nEnforcers is authorized to handle and resolve this matter with you and has already\r\nbeen involved with this case.  Calls directly to Lilly ICOS will not be accepted. \r\nIf Infringer does not respond to this demand as requested by 5:00 p.m. on 4/10/2007,\r\nwe will assume that this demand has been rejected and will proceed accordingly. \r\n \r\n  \r\n \r\nSincerely, \r\n \r\nVCLM Law \r\n \r\n  \r\n \r\nLance C. Venable \r\n \r\nAttorney at Law \r\n \r\n  \r\n \r\nLCV/roc \r\n \r\n  \r\n \r\n  \r\n \r\n \r\nMIME element (text/html) \r\n<html xmlns:v=\"urn:schemas-microsoft-com:vml\"\r\nxmlns:o=\"urn:schemas-microsoft-com:office:office\"\r\nxmlns:w=\"urn:schemas-microsoft-com:office:word\"\r\nxmlns:x=\"urn:schemas-microsoft-com:office:excel\"\r\nxmlns:st1=\"urn:schemas-microsoft-com:office:smarttags\"\r\nxmlns=\"http://www.w3.org/TR/REC-html40\"> \r\n \r\n<head> \r\n<meta http-equiv=Content-Type content=\"text/html; charset=iso-8859-1\"> \r\n<meta name=Generator content=\"Microsoft Word 11 (filtered medium)\"> \r\n<!--[if !mso]> \r\n<style> \r\nv\\:* {behavior:url(#default#VML);} \r\no\\:* {behavior:url(#default#VML);} \r\nw\\:* {behavior:url(#default#VML);} \r\n.shape {behavior:url(#default#VML);} \r\n</style> \r\n<![endif]--><o:SmartTagType \r\n namespaceuri=\"urn:schemas-microsoft-com:office:smarttags\" name=\"country-region\"/> \r\n<o:SmartTagType namespaceuri=\"urn:schemas-microsoft-com:office:smarttags\" \r\n name=\"place\"/> \r\n<o:SmartTagType namespaceuri=\"urn:schemas-microsoft-com:office:smarttags\" \r\n name=\"PersonName\"/> \r\n<!--[if !mso]> \r\n<style> \r\nst1\\:*{behavior:url(#default#ieooui) } \r\n</style> \r\n<![endif]--> \r\n<style> \r\n<!-- \r\n /* Font Definitions */ \r\n @font-face \r\n        {font-family:SimSun; \r\n        panose-1:2 1 6 0 3 1 1 1 1 1;} \r\n@font-face \r\n        {font-family:Tahoma; \r\n        panose-1:2 11 6 4 3 5 4 4 2 4;} \r\n@font-face \r\n        {font-family:\"\\@SimSun\"; \r\n        panose-1:0 0 0 0 0 0 0 0 0 0;} \r\n /* Style Definitions */ \r\n p.MsoNormal, li.MsoNormal, div.MsoNormal \r\n        {margin:0in; \r\n        margin-bottom:.0001pt; \r\n        font-size:12.0pt; \r\n        font-family:\"Times New Roman\";} \r\np.MsoBodyText, li.MsoBodyText, div.MsoBodyText \r\n        {margin:0in; \r\n        margin-bottom:.0001pt; \r\n        text-align:justify; \r\n        font-size:12.0pt; \r\n        font-family:\"Times New Roman\";} \r\np.MsoSalutation, li.MsoSalutation, div.MsoSalutation \r\n        {margin-top:12.0pt; \r\n        margin-right:0in; \r\n        margin-bottom:12.0pt; \r\n        margin-left:0in; \r\n        font-size:12.0pt; \r\n        font-family:\"Times New Roman\";} \r\na:link, span.MsoHyperlink \r\n        {color:blue; \r\n        text-decoration:underline;} \r\na:visited, span.MsoHyperlinkFollowed \r\n        {color:purple; \r\n        text-decoration:underline;} \r\nspan.EmailStyle17 \r\n        {mso-style-type:personal-compose; \r\n        font-family:Arial; \r\n        color:windowtext;} \r\nspan.EmailStyle18 \r\n        {mso-style-type:personal; \r\n        font-family:Arial; \r\n        color:windowtext;} \r\np.BDBodyTextSgl, li.BDBodyTextSgl, div.BDBodyTextSgl \r\n        {margin-top:0in; \r\n        margin-right:0in; \r\n        margin-bottom:12.0pt; \r\n        margin-left:0in; \r\n        font-size:12.0pt; \r\n        font-family:\"Times New Roman\";} \r\np.To, li.To, div.To \r\n        {margin:0in; \r\n        margin-bottom:.0001pt; \r\n        font-size:12.0pt; \r\n        font-family:\"Times New Roman\";} \r\n@page Section1 \r\n        {size:8.5in 11.0in; \r\n        margin:1.0in 1.25in 1.0in 1.25in;} \r\ndiv.Section1 \r\n        {page:Section1;} \r\n--> \r\n</style> \r\n \r\n</head> \r\n \r\n<body lang=EN-US link=blue vlink=purple> \r\n \r\n<div class=Section1> \r\n \r\n<p class=MsoNormal style='line-height:150%'><font size=2 face=Tahoma><span \r\nstyle='font-size:10.0pt;line-height:150%;font-family:Tahoma'>To whom it may \r\nconcern,<o:p></o:p></span></font></p> \r\n \r\n<p class=MsoNormal style='line-height:150%'><font size=2 face=Tahoma><span \r\nstyle='font-size:10.0pt;line-height:150%;font-family:Tahoma'><o:p>&nbsp;</o:p></span></font></p>\r\n\r\n \r\n<p class=MsoNormal style='line-height:150%'><font size=2 face=Tahoma><span \r\nstyle='font-size:10.0pt;line-height:150%;font-family:Tahoma'>This is in regards \r\nto a Cease and Desist letter which was sent to you regarding your client <b><u><span \r\nstyle='font-weight:bold'><a\r\nhref=\"http://www.taldalafil.com/\">www.Taldalafil.com</a></span></u> \r\n</b>and our client <b><span style='font-weight:bold'>Eli Lilly ICOS\r\n(Cialis)</span></b>. \r\nYour client received a DMCA Notification informing them of the unauthorized use \r\nof copyrighted images and trademarked logos. They received this letter on <b><span \r\nstyle='font-weight:bold'>3/27/2007</span></b> and was given eight (8) days to \r\ncomply. The website has been rechecked and I am showing your client has yet to comply. \r\nIn regards to this issue, it should be known that the advertisement or sale of \r\n&#8220;Generic Cialis&#8221; is forbidden inside the <st1:place\r\nw:st=\"on\"><st1:country-region \r\n w:st=\"on\">US</st1:country-region></st1:place>. Simply hosting a website that \r\noffers &#8220;Generic Cialis&#8221; is illegal. Also, the removal of all \r\ninfringing Intellectual Property","date_sent":"2007-04-10T04:00:00Z","date_received":"2007-04-10T04:00:00Z","topics":["Copyright","DMCA Safe Harbor"],"sender_name":null,"principal_name":"Net Enforcers Inc. (for Cialis)","recipient_name":"ThePlanet.com Internet Services Inc","works":[{"description":"Unknown work","infringing_urls":[],"copyrighted_urls":[]}],"tags":[],"jurisdictions":[],"action_taken":"Yes","language":null}}